Recalcitrant Issues and New Frontiers in Nano-Pharmacology
Open Access
- 29 November 2019
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 10, 1369
- https://doi.org/10.3389/fphar.2019.01369
Abstract
Packaging of old pharma drugs into new packaging “nanoparticles” is called nano-pharmacology and the products are called nano-based drugs. The inception of nano-pharmacology research and development (R&D) is marked by the approval of the first nano-based drug Doxil® in 1995 by the Food and Drug Administration. However, even after more than two decades, today, there are only ∼20 nano-based drugs in the market to treat cancers and brain diseases. In this article we share the perspectives of nanotechnology scientists, engineers, and clinicians on the roadblocks in nano-pharmacology R&D. Also, we share our opinion on new frontiers in the field of nano-pharmacology R&D that may allow rapid and efficient transfer of nano-pharma technologies from R&D to market.This publication has 69 references indexed in Scilit:
- Magneto-electric Nanoparticles to Enable Field-controlled High-Specificity Drug Delivery to Eradicate Ovarian Cancer CellsScientific Reports, 2013
- Exploiting the Nanoparticle Plasmon Effect: Observing Drug Delivery Dynamics in Single Cells via Raman/Fluorescence Imaging SpectroscopyACS Nano, 2013
- A Raman-based endoscopic strategy for multiplexed molecular imagingProceedings of the National Academy of Sciences of the United States of America, 2013
- Magneto-Electric Nano-Particles for Non-Invasive Brain StimulationPLOS ONE, 2012
- A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticleNature Medicine, 2012
- Real-Time Monitoring of Glutathione-Triggered Thiopurine Anticancer Drug Release in Live Cells Investigated by Surface-Enhanced Raman ScatteringAnalytical Chemistry, 2012
- Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiformeJournal of Neuro-Oncology, 2010
- A Comparison Between Time Domain and Spectral Imaging Systems for Imaging Quantum Dots in Small Living AnimalsMolecular Imaging & Biology, 2009
- New Technologies for Human Cancer ImagingJournal of Clinical Oncology, 2008
- Diffuse optical imaging of the healthy and diseased breast: A systematic reviewBreast Cancer Research and Treatment, 2007